Policy & Regulation
2 June 2020 - - US-based emerging company developing biotechnology invented at UCLA is adapting their approach to address the novel coronavirus, with the goal of adding to the anti-COVID-19 arsenal th...
2 June 2020 - Pharmaceutical company Eisai Inc reported on Monday the launch of the US FDA approved DAYVIGO (lemborexant) CIV for the treatment of adults with insomnia, characterised by difficulties w...
2 June 2020 - Swedish biopharmaceutical company Camurus AB (NASDAQ:CAMX) (STO:CAMX) announced on Monday that it has filed a request for final approval of Brixadi (buprenorphine) with the US Food and D...
2 June 2020 - PTC Therapeutics Inc (NASDAQ: PTCT), a science-driven, global biopharmaceutical company, has completed the acquisition of Censa Pharmaceuticals Inc, a biopharmaceutical company concentra...
2 June 2020 - Proteostasis Therapeutics Inc (Nasdaq:PTI), a clinical stage biopharmaceutical company, has revealed results from in vitro studies assessing the use of PTI-129 intended for the treatment...
2 June 2020 - Eli Lilly and Company (NYSE: LLY), a global healthcare company, has dosed patients in the first study of LY-CoV555 intended to prevent COVID-19, it was reported on Monday.The product has...
Related Headlines